Money Morning12d
Bird Flu Concerns Boost Moderna Stock: Key Levels Traders Are Watching
Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these ...
Moderna Announces Updates on Pandemic Influenza Program
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
As avian influenza A(H5N1) concerns continue, mRNA vaccines offer great potential
With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...
Sierra Sun Times22h
HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine
HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...
US Bird Flu: H5N1 Influenza Found in a Georgia Commercial Flock for the First Time; All Poultry Activities Suspended
Georgia has suspended all poultry activities after bird flu was confirmed during a commercial poultry operation. The positive ...
Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
Volunteers help with plastic pellet pollution clean-up in Charleston waterways
If that sounds weird, well, kidneys help regulate blood pressure in part through signals from certain nerves. “My blood ...